Publication | Closed Access

Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaReceptor Tyrosine KinaseShingosine Kinase-1PharmacologyCell BiologyCancer ResearchMdr-associated ChemoresistanceTumor BiologyMyeloid Neoplasia